DNMT3A and acute myeloid leukemia: DNMT3A mutations are considered early events in AML [1, 11, 55], usually occur in establishing clonal hematopoiesis, rarely occur alone in AML patients, and are required in conjunction with additional genetic damage to promote AML development [1].